Adverse drug reactions (ADRs) may be the cause of up to 200.000 deaths per year in the EU, with annual costs to society of 80 billion EUR. At the same time, more drugs and, crucially, more combinations of drugs are being prescribed, even though the rate of ADRs increases exponentially once a patient simultaneously takes four or more medications. Since the number of drugs cannot always be reduced, it becomes paramount to detect drug-drug interactions (DDIs) as soon as possible.
We aim to develop an A.I.-based platform able to predict DDIs and warn patients, doctors, and pharmacists if a combination of medications poses the risk of serious ADRs. Depending on a user’s medical knowledge, the platform will provide different levels of information.
This project is a cooperation between Robimo GmbH (lead partner) and the Pharmacoinformatics Research Group and is funded by the Vienna Business Agency (Call Tech4People 2023).
